Page ContentA recently published decision of the Commissioner of Patents in Re Immunex Corporation Patent Application No. 583,9881 has provided prospective Canadian patentees of inventions relating to monoclonal antibodies with some long-sought clarity in this rapidly evolving practice area. (...) Intellectual Property Alert - March 2011 - Canadian Commissioner of Patents Endorses Broad Monoclonal Antibody Claims